Lord, Abbett & Co

Lord, Abbett & Co’s Protagonist Therapeutics PTGX Stock Holding History

Lord, Abbett & Co’s Portfolio PTGX Stock Details PTGX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.2M	Buy
2022 Q2	–	Sell
2022 Q1	$6.53M	Buy
2021 Q4	$5.6M	Buy
2021 Q3	–	Sell
2021 Q2	$6.22M	Buy